Several studies have demonstrated that γ-secretase inhibition can cause neurotoxicity in vivo, supporting BACE1 inhibition being the most effective anti-amyloid target in Aβ production-related AD [6]. This evidence concerns the gene BACE1 and Alzheimer disease.